French studies. A study by Hopital Bicêtre, Bacteriologie...

French studies. A study by Hopital Bicêtre, Bacteriologie Hygiene, France which tested 256 sera from 101 patients hospitalised with SARS-CoV-2 infection (positive RT-PCR), during the period 11 to 23 March 2020 for IgM and IgG using the NG Test IgG / IgM COVID19, has found that“Sensitivity, Specificity, Positive Predictive Value and Negative Predictive Value were 97.0%, 100%, 100% and 96.2%, respectively 15 days after the onset of symptoms.” The research was supported by Assistance Publique – Hôpitaux de Paris (APHP), Médecins Sans Frontières (MSF), and by a Grant from the French Defence Innovation Agency (AID). A copy of the paper (which is a pre-print of the Lancet Infectious Diseases and accordingly, has not been the subject of peer review) can be accessed via this link: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3582814. We note that Dr Alan Finkel, Australia’s Chief Scientist, provided a report to Minister Hunt titled ‘The predictive value of serological testing during the COVID-19 pandemic’ dated 30 April 20203 which concluded that: “For as long as the prevalence of COVID-19 is low in Australia and available serological tests are not approaching 100% specificity, serological testing to measure the prevalence of COVID-19 will not be meaningful.”As noted above, the Hopital Bicêtre study of the COVID-19 antibody test demonstrated 100% specificity. “These results and the proven ease-of-use of Atomo devices in the field, in our opinion,make the test well suited to community deployment and population screening programs.With our exclusive agreement in place and the AtomoRapid COVID-19 (IgG/IgM) product having a CE Mark, we are now in a position to progress regulatory applications within our exclusive jurisdictions in the coming months,” Mr Kelly continued.AtomoRapid COVID-19 (IgG/IgM) is an integrated blood test device designed to determine if a patient has developed antibodies generated in the body in response to the COVID-19 virus. Results are obtained from a drop of blood in 15 minutes.For more information, please contact:Jane Lowe John KellyIR Department Managing Director, At